Post-ERCP pancreatitis: Prevention, diagnosis and management
Endoscopic retrograde cholangiopancreatography (ERCP) carries a post-ERCP pancreatitis
(PEP) rate of 2–10%, which could be as high as 30–50% in high-risk cases. PEP is severe in …
(PEP) rate of 2–10%, which could be as high as 30–50% in high-risk cases. PEP is severe in …
Update on the management of acute pancreatitis
FF van den Berg, MA Boermeester - Current Opinion in Critical …, 2023 - journals.lww.com
More treatment modalities that are less invasive became available and a trend towards less
aggressive treatments (fluids, starvation, interventions, opiates) of acute pancreatitis is again …
aggressive treatments (fluids, starvation, interventions, opiates) of acute pancreatitis is again …
American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations
Methods This document was prepared by the Standards of Practice Committee of the ASGE
and was conceptualized and conducted according to the Grading of Recommendations …
and was conceptualized and conducted according to the Grading of Recommendations …
Guidewire‐assisted cannulation of the common bile duct for the prevention of post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis
Background Cannulation techniques have been recognized as being important in causing
post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) …
post‐endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) …
American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: methodology and review of evidence
Methods The aim of this document is to describe the methodology used in this process and
to provide a detailed review of the evidence used to inform the guideline. It details the …
to provide a detailed review of the evidence used to inform the guideline. It details the …
Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde …
VS Akshintala, CJS Weiland, FA Bhullar… - The Lancet …, 2021 - thelancet.com
Background Non-steroidal anti-inflammatory drugs (NSAIDs), intravenous fluid, pancreatic
stents, or combinations of these have been evaluated in randomised controlled trials (RCTs) …
stents, or combinations of these have been evaluated in randomised controlled trials (RCTs) …
Development and external validation of a nomogram for prediction of post-endoscopic retrograde cholangiopancreatography pancreatitis
R Fukuda, R Hakuta, Y Nakai, T Hamada, S Takaoka… - Pancreatology, 2023 - Elsevier
Background and aims Endoscopic retrograde cholangiopancreatography (ERCP) is widely
performed for management of pancreatobiliary diseases; however, post-ERCP pancreatitis …
performed for management of pancreatobiliary diseases; however, post-ERCP pancreatitis …
Development and validation of a machine learning–based, point-of-care risk calculator for post-ERCP pancreatitis and prophylaxis selection
Background and Aims A robust model of post-ERCP pancreatitis (PEP) risk is not currently
available. We aimed to develop a machine learning–based tool for PEP risk prediction to aid …
available. We aimed to develop a machine learning–based tool for PEP risk prediction to aid …
Utilization pattern of prophylactic measures for prevention of post-ERCP pancreatitis: a National Survey Study
Background and Aims Post-ERCP pancreatitis (PEP) is the most frequent adverse event of
ERCP. Various prophylactic measures are endorsed by the American Society for …
ERCP. Various prophylactic measures are endorsed by the American Society for …
Prevention of post-ERCP complications
L Triki, A Tringali, M Arvanitakis, T Schepis - Best Practice & Research …, 2024 - Elsevier
Endoscopic retrograde cholangiopancreatography (ERCP) is a common endoscopic
procedure which plays a key role in the management of diseases of the bile ducts and the …
procedure which plays a key role in the management of diseases of the bile ducts and the …